000 01507 a2200469 4500
005 20250518094133.0
264 0 _c20210728
008 202107s 0 0 eng d
022 _a1365-2125
024 7 _a10.1111/bcp.14301
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKörber, Iris
245 0 0 _aSafety and immunogenicity of Fc-EDA, a recombinant ectodysplasin A1 replacement protein, in human subjects.
_h[electronic resource]
260 _bBritish journal of clinical pharmacology
_c10 2020
300 _a2063-2069 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aEctodysplasins
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fc Fragments
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aMale
650 0 4 _aPregnancy
650 0 4 _aRecombinant Fusion Proteins
650 0 4 _aResearch Subjects
700 1 _aKlein, Ophir D
700 1 _aMorhart, Patrick
700 1 _aFaschingbauer, Florian
700 1 _aGrange, Dorothy K
700 1 _aClarke, Angus
700 1 _aBodemer, Christine
700 1 _aMaitz, Silvia
700 1 _aHuttner, Kenneth
700 1 _aKirby, Neil
700 1 _aDurand, Caroline
700 1 _aSchneider, Holm
773 0 _tBritish journal of clinical pharmacology
_gvol. 86
_gno. 10
_gp. 2063-2069
856 4 0 _uhttps://doi.org/10.1111/bcp.14301
_zAvailable from publisher's website
999 _c30817989
_d30817989